Barclays Maintains Overweight on Exelon, Lowers Price Target to $41
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Eric Beaumont has maintained an Overweight rating on Exelon (NASDAQ:EXC) but lowered the price target from $43 to $41.

October 24, 2023 | 1:43 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Exelon's price target has been lowered from $43 to $41 by Barclays, though the Overweight rating is maintained.
The news is directly about Exelon and is likely to influence investor sentiment. The lowering of the price target might be seen as a negative signal, but the maintenance of the Overweight rating indicates that Barclays still sees potential in the stock. The net impact on the stock price in the short term is uncertain.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100